Pathological complete response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with unresectable BRAF V600E-mutant malignant melanoma of the gallbladder

Historically, patients with locally advanced or metastatic melanoma have an extremely poor prognosis. In recent years, major breakthroughs in cutaneous melanoma treatment have led to remarkable improvements in patient outcomes. However, there are limited published data on the efficacy of these novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zhou, Quiroz, Elisa, Shen, Yulei, Jaiyesimi, Ishmael A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287667/
https://www.ncbi.nlm.nih.gov/pubmed/30584330
http://dx.doi.org/10.2147/OTT.S177111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287667/
https://www.ncbi.nlm.nih.gov/pubmed/30584330
http://dx.doi.org/10.2147/OTT.S177111

Ejemplares similares